Journal of Biological Chemistry
Volume 295, Issue 43, 23 October 2020, Pages 14710-14722
Journal home page for Journal of Biological Chemistry

Glycobiology and Extracellular Matrices
Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2

https://doi.org/10.1074/jbc.RA120.014407Get rights and content
Under a Creative Commons license
open access

Notch signaling is a cellular pathway regulating cell-fate determination and adult tissue homeostasis. Little is known about how canonical Notch ligands or Fringe enzymes differentially affect NOTCH1 and NOTCH2. Using cell-based Notch signaling and ligand-binding assays, we evaluated differences in NOTCH1 and NOTCH2 responses to Delta-like (DLL) and Jagged (JAG) family members and the extent to which Fringe enzymes modulate their activity. In the absence of Fringes, DLL4–NOTCH1 activation was more than twice that of DLL4–NOTCH2, whereas all other ligands activated NOTCH2 similarly or slightly more than NOTCH1. However, NOTCH2 showed less sensitivity to the Fringes. Lunatic fringe (LFNG) enhanced NOTCH2 activation by DLL1 and -4, and Manic fringe (MFNG) inhibited NOTCH2 activation by JAG1 and -2. Mass spectral analysis showed that O-fucose occurred at high stoichiometry at most consensus sequences of NOTCH2 and that the Fringe enzymes modified more O-fucose sites of NOTCH2 compared with NOTCH1. Mutagenesis studies showed that LFNG modification of O-fucose on EGF8 and -12 of NOTCH2 was responsible for enhancement of DLL1–NOTCH2 activation, similar to previous reports for NOTCH1. In contrast to NOTCH1, a single O-fucose site mutant that substantially blocked the ability of MFNG to inhibit NOTCH2 activation by JAG1 could not be identified. Interestingly, elimination of the O-fucose site on EGF12 allowed LFNG to inhibit JAG1-NOTCH2 activation, and O-fucosylation on EGF9 was important for trafficking of both NOTCH1 and NOTCH2. Together, these studies provide new insights into the differential regulation of NOTCH1 and NOTCH2 by Notch ligands and Fringe enzymes.

Notch receptor
glycosylation
glycosyltransferase
signal transduction
mass spectrometry
NOTCH1
NOTCH2
Fringe
mass spectrometry (MS)

Cited by (0)

This article contains supporting information.

Author contributions—S. K. and R. K. L. data curation; S. K. and R. S. H. formal analysis; S. K., R. K. L., and A. I. investigation; S. K. and A. I. methodology; S. K. writing-original draft; S. K., R. K. L. and R. S. H. writing-review and editing; A. I. and R. S. H. resources; R. S. H. conceptualization; R. S. H. supervision; R. S. H. funding acquisition; R. S. H. project administration.

Funding and additional information—This work was supported by National Institutes of Health Grant GM061126 (to R. S. H.) and the Georgia Research Alliance. R. K. L. was partially supported by National Institutes of Health Grant T32GM107004. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.

Abbreviations—The abbreviations used are:

    DLL

    Delta-like ligand

    JAG

    Jagged

    LFNG

    Lunatic fringe

    MFI

    mean fluorescence intensity

    MFNG

    Manic fringe

    POFUT1

    protein O-fucosyltransferase 1

    RFNG

    Radical fringe

    EGF

    epidermal growth factor–like

    ECD

    extracellular domain

    ER

    endoplasmic reticulum

    PE

    phycoerythrin

    RT

    room temperature

    EV

    empty vector

    RLU

    relative luciferase units

    ANOVA

    analysis of variance.